首页> 外文期刊>Journal of immunology research. >Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation
【24h】

Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation

机译:尖端:免疫调节中的益生菌和粪便微生物会移植

获取原文
           

摘要

Probiotics are commensal or nonpathogenic microbes that confer beneficial effects on the host through several mechanisms such as competitive exclusion, antibacterial effects, and modulation of immune responses. Some probiotics have been found to regulate immune responses via immune regulatory mechanisms. T regulatory (Treg) cells, T helper cell balances, dendritic cells, macrophages, B cells, and natural killer (NK) cells can be considered as the most determinant dysregulated mediators in immunomodulatory status. Recently, fecal microbiota transplantation (FMT) has been defined as the transfer of distal gut microbial communities from a healthy individual to a patient’s intestinal tract to cure some immune disorders (mainly inflammatory bowel diseases). The aim of this review was followed through the recent literature survey on immunomodulatory effects and mechanisms of probiotics and FMT and also efficacy and safety of probiotics and FMT in clinical trials and applications.
机译:益生菌是共生或非致病微生物,通过诸如竞争排除,抗菌作用和免疫反应的调节等若干机制赋予宿主的有益影响。已经发现一些益生菌通过免疫调节机制调节免疫应答。 T调节(Treg)细胞,T辅助细胞平衡,树突细胞,巨噬细胞,B细胞和天然杀伤(NK)细胞可以被认为是免疫调节状态下最决定性的失餐介质。最近,粪便微生物会移植(FMT)被定义为从健康个体转移到患者的肠道中的远端肠道微生物社区,以治愈一些免疫疾病(主要是炎症性肠病)。该审查的目的是通过最近关于免疫调节效果和益生菌和FMT机制的文献调查以及益生菌和FMT在临床试验和应用中的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号